Richard Weaver

"Don't think that just because you've done a Biology or Chemistry degree, this is your path forever....I didn't become an entrepreneur until the age of 42. Your [career] path isn't fixed." Richard Weaver is a consultant to Biotech companies on their drug development programmes, specialising in DMPK. Before becoming a consultant, Rich was the founder of XenoGesis, a CRO he successfully sold to Sygnature Discovery in 2020. Rich talked to us about his career as a scientist and an entrepreneur, his formula for building a CRO and the advantages of organic growth. Enjoy!

Om Podcasten

Careers in Discovery is your window into the world of Pharma & Biotech. Featuring interviews each week with leaders in Drug Discovery and R&D, you'll learn about the careers of these influential figures, the work they are doing, how they got to where they are and what advice they'd give their younger selves. Brought to you by Singular Talent. Connect with us at: Twitter: @singular_talent LinkedIn: www.linkedin.com/company/singular-talent www.singulartalent.io